I
Power Law company profile
Inversago Pharma
Biotech & Life Sciences · St-Eustache, Canada · Founded 2015 Unicorn
Global footprint
Where Inversago Pharma has talent and traffic
Web traffic by country
2.7K
monthly visits
across markets
across markets
🇺🇸 United States48.1%
🇨🇦 Canada37%
🇮🇹 Italy7.4%
🇹🇷 Turkey3.7%
🇮🇳 India3.7%
Patent intelligence
$179k patent portfolio · 2 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$179k
0.02% of valuation · 915.1× smaller than top peer Amicus Therapeutics ($164M)
2 active patent families
Where Inversago Pharma innovates
PharmacologyCannabinoid receptorDiseasePyrazolePharmaceutical drug
Above peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Inversago Pharma on the five Patsnap quality dimensions
Inversago Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Inversago Pharma concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Inversago Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Inversago Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.